Breaking away: High fracture rates may merit a new trial of adjuvant endocrine therapy in Scandinavian breast cancer patients

Authors

  • Håvard Søiland Stavanger University Hospital, Department of Surgery, Section for Breast and Endocrine Surgery, Stavanger, Norway; University of Bergen, Institute of Surgical Sciences, Bergen, Norway
  • Kari Britt Hagen Haukeland University Hospital, Department of Breast and Endocrine Surgery, Bergen, Norway
  • Jennifer Gjerde Haukeland University Hospital, Hormonlaboratoriet, Bergen, Norway
  • Tone Hoel Lende Stavanger University Hospital, Department of Surgery, Section for Breast and Endocrine Surgery, Stavanger, Norway
  • Ernst A. Lien University of Bergen, Institute of Medicine, Bergen, Norway; Haukeland University Hospital, Hormonlaboratoriet, Bergen, Norway

DOI:

https://doi.org/10.3109/0284186X.2012.742963

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2013-05-01

How to Cite

Søiland, H., Britt Hagen, K., Gjerde, J., Hoel Lende, T., & Lien, E. A. (2013). Breaking away: High fracture rates may merit a new trial of adjuvant endocrine therapy in Scandinavian breast cancer patients. Acta Oncologica, 52(4), 861. https://doi.org/10.3109/0284186X.2012.742963

Issue

Vol. 52 No. 4 (2013): Acta Oncologica

Section

Articles